Back
Milestone Pharmaceuticals Vs. Nebius Group NV Industry Stock Comparison
Sell
47
MIST
Milestone Pharmaceuticals
Last Price:
$1.96
Seasonality Move:
-21.27%
Buy
54
NBIS
Nebius Group NV
Last Price:
$36.82
Seasonality Move:
-3.94%
Sell
47
Milestone Pharmaceuticals (MIST)
is a Sell
Is Milestone Pharmaceuticals a Buy, Sell or Hold?
-
The current Milestone Pharmaceuticals [MIST] share price is $1.97. The Score for MIST is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
MIST is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Nebius Group NV (NBIS)
is a Buy
Is Nebius Group NV a Buy, Sell or Hold?
-
The current Nebius Group NV [NBIS] share price is $35.72. The Score for NBIS is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
NBIS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MIST Stock Price Chart
What is Milestone Pharmaceuticals's stock price today?
-
The Milestone Pharmaceuticals share price today is $1.97The current trend is moderately bearish and MIST is experiencing selling pressure, which indicates risk of future bearish movement.
NBIS Stock Price Chart
What is Nebius Group NV's stock price today?
-
The Nebius Group NV share price today is $35.72Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBIS is experiencing buying pressure, which is a positive indicator for future bullish movement.
MIST Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.09 | Buy |
Relative Strength Index (14 RSI): | 48.34 | Sell |
Chaikin Money Flow: | -484705 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.78 - 2.16) | Sell |
Bollinger Bands (100): | (1.43 - 1.93) | Buy |
NBIS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.73 | Buy |
Relative Strength Index (14 RSI): | 67.88 | Buy |
Chaikin Money Flow: | 9835639 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (27.78 - 33.26) | Buy |
Bollinger Bands (100): | (17.36 - 27.78) | Buy |
MIST Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.17 | Sell |
20-day SMA: | 2 | Sell |
50-day SMA: | 1.88 | Buy |
200-day SMA: | 1.61 | Buy |
8-day EMA: | 2.11 | Sell |
20-day EMA: | 2.04 | Sell |
50-day EMA: | 1.89 | Buy |
200-day EMA: | 1.8 | Buy |
NBIS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 31.47 | Buy |
20-day SMA: | 29.83 | Buy |
50-day SMA: | 26.05 | Buy |
200-day SMA: | 20.76 | Buy |
8-day EMA: | 31.92 | Buy |
20-day EMA: | 30.12 | Buy |
50-day EMA: | 27.05 | Buy |
200-day EMA: | 22.06 | Buy |
Milestone Pharmaceuticals Earnings Growth & MIST Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.20 per share, and an increase next year of $0.95 per share.
Nebius Group NV Earnings Growth & NBIS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Milestone Pharmaceuticals Technical Analysis
Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nebius Group NV Technical Analysis
Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |